Syros Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SYRS and buy or sell other stocks, ETFs, and their options commission-free!About SYRS
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609.
CEONancy A. Simonian
CEONancy A. Simonian
Employees124
Employees124
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees124
Employees124
SYRS Key Statistics
Market cap25.20K
Market cap25.20K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume5.31M
Average volume5.31M
High today$0.01
High today$0.01
Low today$0.0004
Low today$0.0004
Open price$0.0004
Open price$0.0004
Volume6.79K
Volume6.79K
52 Week high$5.22
52 Week high$5.22
52 Week low$0.0004
52 Week low$0.0004
Stock Snapshot
The current Syros Pharmaceuticals(SYRS) stock price is $0.00, with a market capitalization of 25.2K.
On 2026-05-06, Syros Pharmaceuticals(SYRS) stock traded between a low of $0.00 and a high of $0.01. Shares are currently priced at $0.00, which is 0.0% above the low and -96.0% below the high.
The Syros Pharmaceuticals(SYRS)'s current trading volume is 6.79K, compared to an average daily volume of 5.31M.
During the past year, Syros Pharmaceuticals(SYRS) stock moved between $0.00 at its lowest and $5.22 at its peak.
During the past year, Syros Pharmaceuticals(SYRS) stock moved between $0.00 at its lowest and $5.22 at its peak.
People also own
Based on the portfolios of people who own SYRS. This list is generated using Robinhood data, and it’s not a recommendation.